End plates resorptions after the applications of rhBMP-2 for interbody spinal fusions.
Smoljanovic
Tomislav
T
Bojanic
Ivan
I
Pecina
Marko
M
D000328:Adult; D000368:Aged; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000008:administration & dosage* / Q000009:adverse effects*; D001860:Bone Plates / Q000009:adverse effects*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005260:Female; D006801:Humans; D007593:Joint Instability / Q000209:etiology* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D011475:Prosthesis Failure; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000009:adverse effects*; D018570:Risk Assessment; D013123:Spinal Fusion / Q000009:adverse effects* / Q000295:instrumentation*; D016212:Transforming Growth Factor beta / Q000008:administration & dosage* / Q000009:adverse effects*
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2